AAAAAA
Results: 1-25/26
Authors:
Baranovskii, AG
Ershova, NA
Buneva, VN
Kanyshkova, TG
Mogelnitskii, AS
Doronin, BM
Boiko, AN
Gusev, EI
Favorova, OO
Nevinsky, GA
Citation: Ag. Baranovskii et al., Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis, IMMUNOL LET, 76(3), 2001, pp. 163-167
Authors:
Kazantseva, NV
Gusev, EI
Makarova, LD
Petuhov, EB
Citation: Nv. Kazantseva et al., Barotherapy in cepebrovascular diseases, ZH NEVR PS, 2001, pp. 48-55
Authors:
Bryun, EA
Gekht, AB
Polunina, AG
Davydov, DM
Gusev, EI
Citation: Ea. Bryun et al., Neuropsychologic deficit in chronic heroin abusers, ZH NEVR PS, 101(3), 2001, pp. 10-19
Authors:
Gusev, EI
Bogolepova, AN
Citation: Ei. Gusev et An. Bogolepova, Nikolay K. Bogolepov (the 100-th anniversary of birth), ZH NEVR PS, 101(2), 2001, pp. 39-40
Authors:
Gusev, EI
Martynov, MY
Yasamanova, AN
Kolesnikova, TI
Kabanov, AA
Petukhov, EB
Berezov, VP
Citation: Ei. Gusev et al., The etiology and risk factors of chronic cerebrovascular disease and ischemic stroke, ZH NEVR PS, 2001, pp. 41-45
Authors:
Boiko, AN
Guseva, ME
Guseva, MR
Boiko, SY
Sudomoina, MA
Bikova, OV
Maslova, OI
Favorova, OO
Gusev, EI
Citation: An. Boiko et al., Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children, J NEUROVIRO, 6, 2000, pp. S152-S155
Authors:
Gusev, EI
Skvortsova, VI
Dambinova, SA
Raevskiy, KS
Alekseev, AA
Bashkatova, VG
Kovalenko, AV
Kudrin, VS
Yakovleva, EV
Citation: Ei. Gusev et al., Neuroprotective effects of glycine for therapy of acute ischaemic stroke, CEREB DIS, 10(1), 2000, pp. 49-60
Authors:
Boyko, AN
Khachanova, NV
Buglak, AV
Demina, TL
Belyaeva, IA
Lash, NV
Serkov, SV
Gusev, EI
Citation: An. Boyko et al., Possibility of the use of several clinical, genetic and MRI characteristics for prognosis of effects of betaferon-1b treatment in multiple sclerosis, IAN FIZ, 64(11), 2000, pp. 53-59
Authors:
Gusev, EI
Belyaeva, IA
Chekhonin, VP
Demina, TL
Boyko, AN
Buglak, AV
Gurina, OI
Citation: Ei. Gusev et al., Comparative clinical immunologic analysis of the remittent and secondary-progressive course of multiple sclerosis, ZH NEVR PS, 100(6), 2000, pp. 51-57
Authors:
Gusev, EI
Skvortsova, VI
Diankina, MS
Aristova, RA
Burd, GS
Levitskaya, NI
Lenichenko, VP
Citation: Ei. Gusev et al., Control and estimation of the knowledge quality of students and physicians, ZH NEVR PS, 100(5), 2000, pp. 55-57
Authors:
Boyko, AN
Khachanova, NV
Buglak, AV
Demina, TL
Belyaeva, IA
Lash, NV
Serkov, SV
Gusev, EI
Citation: An. Boyko et al., Possibility of the use of several clinical, genetic and MRI characteristics for prognosis of effects of betaferon-1b treatment in multiple sclerosis, ZH NEVR PS, 100(12), 2000, pp. 53-59
Authors:
Alekseeva, TG
Boiko, AN
Gusev, EI
Citation: Tg. Alekseeva et al., Spectrum of neuropsychologic changes in multiple sclerosis, ZH NEVR PS, 100(11), 2000, pp. 15-20
Authors:
Gusev, EI
Boyko, AN
Citation: Ei. Gusev et An. Boyko, The modern approaches to beta-interferon application in therapy of multiple sclerosis, ZH NEVR PS, 100(11), 2000, pp. 54-59
Authors:
Belyaeva, IA
Gusev, EI
Chekhonin, VP
Demina, TL
Boiko, AN
Buglak, AV
Citation: Ia. Belyaeva et al., Blood-brain barrier, ZH NEVR PS, 99(8), 1999, pp. 57-62
Authors:
Gekht, AB
Avakyan, GN
Gusev, EI
Citation: Ab. Gekht et al., Modern standards of diagnosis and treatment of epilepsy in Europe, ZH NEVR PS, 99(7), 1999, pp. 4-7
Authors:
Gusev, EI
Boyko, AN
Demina, TL
Sudomoina, MA
Alekseev, LP
Boldyreva, MN
Trofimov, DY
Favorova, OO
Citation: Ei. Gusev et al., Risk factors of the development of multiple sclerosis in Moscow population: combination of exogenic and hereditary factors, ZH NEVR PS, 99(6), 1999, pp. 47-52
Authors:
Skvortsova, VI
Nasonov, EL
Zhuravlyeva, EY
Grivennikov, IA
Arsenyeva, EL
Sukhanov, II
Myasoedov, NF
Gusev, EI
Citation: Vi. Skvortsova et al., Clinical-immunobiochemical monitoring of the factors of local inflammationin the acute period of hemispheric ischemic stroke, ZH NEVR PS, 99(5), 1999, pp. 27-31
Authors:
Gusev, EI
Boyko, AN
Smirnova, NF
Demina, TL
Citation: Ei. Gusev et al., Risk factors of development of multiple sclerosis in Moscow population, ZH NEVR PS, 99(5), 1999, pp. 32-40
Authors:
Gusev, EI
Skvortsova, VI
Zhuravleva, EY
Yakovleva, EV
Citation: Ei. Gusev et al., Mechanisms of brain tissue damage in acute focal ischemia, ZH NEVR PS, 99(5), 1999, pp. 55-61
Authors:
Gusev, EI
Boiko, AN
Pozer, C
Citation: Ei. Gusev et al., Problems and perspectives of application of beta-interferons and copaxon in the treatment of multiple sclerosis, ZH NEVR PS, 99(4), 1999, pp. 33-36
Authors:
Gusev, EI
Skvortsova, VI
Komissarova, IA
Dambinova, SA
Raevsky, KS
Alekseev, AA
Bashkatova, VG
Kovalenko, AV
Kudrin, VS
Yakovleva, EV
Citation: Ei. Gusev et al., Neuroprotective effect of glycine in the acute period of ischemic stroke, ZH NEVR PS, 99(2), 1999, pp. 12-20
Authors:
Skvortsova, VI
Raevsky, KS
Kovalenko, AV
Kudrin, VS
Malikova, LA
Sokolov, MA
Alekseev, AA
Gusev, EI
Citation: Vi. Skvortsova et al., The levels of neurotransmitter amino acids in cerebrospinal fluid of patients with acute cerebral stroke, ZH NEVR PS, 99(2), 1999, pp. 34-38
Authors:
Gusev, EI
Skvortsova, VI
Kovalenko, AV
Sokolov, MA
Citation: Ei. Gusev et al., Mechanisms of brain tissue damage from acute focal cerebral ischemia, ZH NEVR PS, 99(2), 1999, pp. 65-70
Authors:
Alexeenkov, AD
Sudomoina, MA
Boiko, AN
Deomina, TL
Gusev, EI
Favorova, OO
Citation: Ad. Alexeenkov et al., Two single-base polymorphisms in the human tumor necrosis factor locus of multiple sclerosis patients from the Russian population: NcoI-RFLP in the first intron of the human lymphotoxin alpha gene correlates with the disease, MOL BIOL, 33(2), 1999, pp. 158-164
Authors:
Gusev, EI
Nikonov, AA
Skvortsova, VI
Avakyan, GN
Gordeeva, TN
Katunina, EA
Atayan, AV
Citation: Ei. Gusev et al., A treatment of a vertigo with betaserk in patients with vascular and traumatic cerebral damages, ZH NEVR PS, 98(11), 1998, pp. 19-21